← back to search

Erjin Xu

Guangzhou University of Chinese Medicine · CN
Area of research
Molecular Biology · Genetics
Research interest
Research interests include Neuroinflammation, MPTP, Neuroprotection, Oxidative stress, Neurodegeneration, and Substantia nigra.
h-index
—
citations
126
works
2
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model
International Immunopharmacology 2019cited by 100position: middledoi
Bushen‐Yizhi Formula Alleviates Neuroinflammation via Inhibiting NLRP3 Inflammasome Activation in a Mouse Model of Parkinson’s Disease
Evidence-based Complementary and Alternative Medicine 2018cited by 26position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yonggen Chen · Guangzhou University of Chinese Medicine2 papers (2018–2019)Baoluu Le · Guangzhou University of Chinese Medicine2 papers (2018–2019)Renrong Wei · Guangzhou University of Chinese Medicine2 papers (2018–2019)Cong Yang · Guangzhou University of Chinese Medicine2 papers (2018–2019)Yousheng Mo · Guangzhou University of Chinese Medicine2 papers (2018–2019)Shaoling Li · Guangzhou University of Chinese Medicine1 papers (2019–2019)Xiaotian Ji · Guangzhou University of Chinese Medicine1 papers (2018–2018)Huihong Wen · Guangzhou University of Chinese Medicine1 papers (2019–2019)Huafeng Pan · Guangzhou University of Chinese Medicine1 papers (2019–2019)Qi Wang · Hebei Medical University1 papers (2019–2019)Shuiqing Huang · Guangzhou University of Chinese Medicine1 papers (2019–2019)Shengqiang Wang · Guangxi University1 papers (2019–2019)Jiayi Zheng · Tongji University1 papers (2019–2019)Weirong Li · Guangzhou University of Chinese Medicine1 papers (2019–2019)Shuhuan Fang · Guangzhou University of Chinese Medicine1 papers (2018–2018)Jiangang Shen · Guangzhou University of Chinese Medicine1 papers (2018–2018)Lei Song · Guangzhou University of Chinese Medicine1 papers (2018–2018)